Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted December 7, 2014
FDA Raises Concerns Over Generic ADHD Drugs
On November 13, 2014, the U.S. FDA expressed concerns about whether two approved generic versions of Concerta tablets (methylphenidate hydrochloride extended-release tablets), used to treat attention-deficit hyperactivity disorder in adults and children, are therapeutically equivalent to the brand-name drug. The two approved generic versions of Concerta in question are manufactured by Mallinckrodt Pharmaceuticals and Kudco Ireland Ltd.
Join today to unlock all member benefits including full access to all recalls & warningsJoin Now
Already a member? Sign In Here.
Join now at www.consumerlab.com/join/